InvestorsHub Logo
Followers 8
Posts 303
Boards Moderated 0
Alias Born 01/02/2018

Re: Homebrew post# 1391

Thursday, 07/18/2019 11:54:13 AM

Thursday, July 18, 2019 11:54:13 AM

Post# of 35961
Can this be stickied. Updated Clinical Trail information:

https://www.mdpi.com/2072-6694/11/6/833
Received: 22 May 2019; Accepted: 13 June 2019; Published: 17 June 2019

"In this study, exploratory analyses suggested that mipsagargin decreased blood flow in HCC lesions and in metastatic sites relative to baseline examination within two cycles of exposure to mipsagargin. These findings warrant a larger clinical study to further characterize the activity of mipsagargin in advanced HCC."

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RBSH News